Announcements

27 August 2025
Future Pharmacology | Aims Update

To further enhance the quality of Future Pharmacology (ISSN: 2673-9879) and the papers published in it, under the guidance of our Editor-in-Chief, Prof. Dr. Fabrizio Schifano, the journal has updated and revised its aims. All new updates can be seen below:

Aims (new version):

Aims (old version):

Future Pharmacology (ISSN 2673-9879) is an international, peer-reviewed, open access journal on basic pharmacology, clinical pharmacology, drug discovery, and therapeutics published quarterly online by MDPI. It aims to achieve a better understanding and dissemination of pharmacological sciences. The journal focuses on publishing full research papers, reviews, and communications, but other article types will also be considered. Authors are encouraged to publish their results in as much detail as possible.

Future Pharmacology will consider manuscripts within the field of complementary medicine or alternative medicine only if they are focused on pharmacological research. Regarding submissions involving natural products or chemical compounds, please see our Instructions for Authors for the requirements for natural product and chemical compound identification studies. Full experimental details must be provided so that the results can be reproduced.

Future Pharmacology (ISSN 2673-9879) is an international, peer-reviewed, open access journal on basic pharmacology, clinical pharmacology, drug discovery, and therapeutics published quarterly online by MDPI. It aims to achieve a better understanding and dissemination of pharmacological sciences. The journal publishes full research papers, reviews, and communications. Authors are encouraged to publish their results in as much detail as possible.

For more detailed information, please visit the following link: https://www.mdpi.com/journal/futurepharmacol/about.

Future Pharmacology Editorial Office

More News...
Back to TopTop